Career history of Neil M. Frazer
Former positions of Neil M. Frazer
| Companies | Position | Start | End |
|---|---|---|---|
| ONCOSIL MEDICAL LIMITED | Director/Board Member | 2013-07-01 | 2014-11-27 |
| Chief Executive Officer | 2013-07-01 | 2014-09-08 | |
| Chief Tech/Sci/R&D Officer | 2014-09-08 | 2014-11-27 | |
DMK Pharmaceuticals Corp. (Old)
 DMK Pharmaceuticals Corp. (Old) BiotechnologyHealth Technology DMK Pharmaceuticals Corp. (Old) was an American commercial stage neuro-biotech company that focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders. The company's approved products included Zimhi® (naloxone) injection for the treatment of opioid overdose and Symjepi® (epinephrine) injection for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The company was founded by Neil M. Frazer and Ebrahim Versi. DMK Pharmaceuticals Corp. was acquired by DMK Pharmaceuticals Corp. on May 25, 2023 for $27 million. | Founder | - | - |
| Corporate Officer/Principal | - | - | |
| IMMUTEP LIMITED | Director/Board Member | 2010-07-25 | 2012-05-23 |
| Chief Tech/Sci/R&D Officer | 2011-01-02 | - | |
| Corporate Officer/Principal | 2011-01-02 | 2011-01-02 | |
| CHIMERIX, INC. | Chief Tech/Sci/R&D Officer | - | - |
Training of Neil M. Frazer
| The University of Edinburgh | Undergraduate Degree |
Statistics
International
| United States | 3 |
| Australia | 3 |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| IMMUTEP LIMITED | Health Technology |
| ONCOSIL MEDICAL LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
DMK Pharmaceuticals Corp. (Old)
DMK Pharmaceuticals Corp. (Old) BiotechnologyHealth Technology DMK Pharmaceuticals Corp. (Old) was an American commercial stage neuro-biotech company that focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders. The company's approved products included Zimhi® (naloxone) injection for the treatment of opioid overdose and Symjepi® (epinephrine) injection for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The company was founded by Neil M. Frazer and Ebrahim Versi. DMK Pharmaceuticals Corp. was acquired by DMK Pharmaceuticals Corp. on May 25, 2023 for $27 million. | Health Technology |
- Stock Market
- Insiders
- Neil M. Frazer
- Experience
